This event has passed.
Webinar ‘Beyond Automation: Towards a Smart Factory’
This event has passed.
Webinar ‘Beyond Automation: Towards a Smart Factory’
Webinar Replay
about the Event
At Bachem, we are constantly striving to improve our industry standards by developing innovative and efficient large-scale manufacturing processes for active pharmaceutical ingredients (APIs). Thereby, our operations entered the Industry 4.0 era and started their business transformation towards a smart factory. Watching this webinar, you will learn more about our transformation journey. Using the solid-phase peptide synthesis (SPPS) process as a case study, we will present how Bachem optimizes equipment usage, reduces operating times, and increases the flexibility of production by implementing process automation. We will also report on the benefits of our digitalization strategy, such as paperless documentation, improved first-time right rates, data analytics, and higher data safety and integrity.
Join us at Bachem 360 Showroom.
https://go.bachem.com/l/919193/2022-07-15/vysl2
ICal and gCal can be downloaded at the botoom of this page.
​
Speakers
Dr. Patrizia Marchetti
Group Leader MSAT at Bachem AG.
Patrizia leads the MSAT process engineering group at Bachem Bubendorf. Her team focuses on the design and implementation of new processes and equipment for the manufacturing of API. Patrizia joined Bachem in 2017 as a technical Project Manager, leading CAPEX projects for the production department. Before joining Bachem, she worked as a researcher at Lonza, Visp and at Imperial College London, developing nanofiltration-assisted processes for peptides and oligonucleotides.
Dr. Elodie Decuypere
Marketing Specialist at Bachem AG
Elodie joined Bachem in 2020 as a Specialist Marketing in the Global Marketing Department. She graduated in Organic Chemistry from the University of Montpellier in 2013 and obtained her PhD degree from the French Atomic Commission in 2016. Before joining Bachem, she worked as a postdoctoral fellow on oligonucleotides synthesis at the ETH Zurich and at Roche.